XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Summary of Significant Accounting Policies - Revenue from contract with customers (Details) £ in Millions | 1 Months Ended | 3 Months Ended | 9 Months Ended | 13 Months Ended | 53 Months Ended
--- | --- | --- | --- | --- | ---
Sep. 30, 2018 USD ($) | Sep. 30, 2017 GBP (£) | Sep. 30, 2017 USD ($) | Jun. 30, 2014 USD ($) | Sep. 30, 2018 USD ($) | Sep. 30, 2017 USD ($) | Sep. 30, 2018 USD ($) Milestone contract | Sep. 30, 2017 USD ($) | Sep. 30, 2018 USD ($) | Sep. 30, 2018 USD ($)
Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  | $ 40,792,000 | $ 27,185,000 | $ 58,026,000 | $ 33,563,000 |  |
PRAME program |  |  |  |  |  |  |  |  |  |
Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Number of small-dollar development milestone | Milestone |  |  |  |  |  |  | 1 |  |  |
GlaxoSmithKline Intellectual Property Development Ltd | Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Number of contracts with customers | contract |  |  |  |  |  |  | 1 |  |  |
Option Exercise Fee, received |  | £ 20 | $ 26,600,000 |  |  |  |  |  |  |
Upfront payment received |  |  |  | $ 42,123,000 |  |  |  |  |  |
Amount of development milestone achieved |  |  |  |  |  |  |  |  |  | $ 66,404,000
Estimate of variable consideration |  |  |  |  |  |  | $ 0 |  |  |
License revenue |  |  |  |  |  |  |  |  |  |
Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Revenue |  |  |  |  | $ 39,114,000 |  | $ 39,114,000 |  |  |
License revenue | GlaxoSmithKline Intellectual Property Development Ltd | Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Collaboration and License Agreement |  |  |  |  |  |  |  |  |  |
Revenue | $ 13,175,000 |  | $ 26,610,000 |  |  |  |  |  | $ 39,785,000 |

X
- Definition Represents cash received upon achievement of development milestones. + References No definition available. + Details
Name: | adap_LicenseAgreementAchievementOfDevelopmentMilestones
Namespace Prefix: | adap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the variable consideration entitled upon achievement of development milestones. + References No definition available. + Details
Name: | adap_LicenseAgreementVariableConsideration
Namespace Prefix: | adap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of first tranche of the option exercise fee receivable for exercising of agreement. + References No definition available. + Details
Name: | adap_LicenseExerciseFeeReceivable
Namespace Prefix: | adap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the total number of contracts with customers. + References No definition available. + Details
Name: | adap_NumberOfContractsWithCustomer
Namespace Prefix: | adap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of small-dollar development milestone the Company may be entitled for pre-clinical development. + References No definition available. + Details
Name: | adap_NumberOfSmallDollarDevelopmentMilestoneEntitlement
Namespace Prefix: | adap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=adap_CollaborativeArrangementPerformanceObligationsForPRMEProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=adap_GlaxosmithklineIntellectualPropertyDevelopmentLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |